|
TRIM27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.834270E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.401400E-03 |
| Normal-vs-Stage2 |
8.127600E-01 |
| Normal-vs-Stage3 |
3.572000E-01 |
| Normal-vs-Stage4 |
9.610400E-02 |
| Stage1-vs-Stage2 |
7.951900E-02 |
| Stage1-vs-Stage3 |
8.108400E-02 |
| Stage1-vs-Stage4 |
6.269600E-01 |
| Stage2-vs-Stage3 |
6.690200E-01 |
| Stage2-vs-Stage4 |
2.931000E-01 |
| Stage3-vs-Stage4 |
3.832200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.671900E-02 |
| Normal-vs-AfricanAmerican |
6.158500E-03 |
| Normal-vs-Asian |
2.501900E-02 |
| Caucasian-vs-AfricanAmerican |
8.394400E-02 |
| Caucasian-vs-Asian |
5.116300E-02 |
| AfricanAmerican-vs-Asian |
5.213600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.089000E-01 |
| Normal-vs-Female |
6.07470000000276E-05 |
| Male-vs-Female |
2.047500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.881800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.490300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.083920E-02 |
| Normal-vs-Age(81-100Yrs) |
6.384800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.376200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.591610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.245000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.996600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.367400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.840200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.416400E-03 |
| Normal-vs-Grade 2 |
7.215800E-04 |
| Normal-vs-Grade 3 |
3.874400E-01 |
| Normal-vs-Grade 4 |
4.022400E-01 |
| Grade 1-vs-Grade 2 |
5.108800E-01 |
| Grade 1-vs-Grade 3 |
7.207900E-02 |
| Grade 1-vs-Grade 4 |
1.362590E-01 |
| Grade 2-vs-Grade 3 |
4.437200E-03 |
| Grade 2-vs-Grade 4 |
7.829600E-02 |
| Grade 3-vs-Grade 4 |
8.162000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.240500E-03 |
| Normal-vs-ccB subtype |
4.689800E-01 |
| ccA subtype-vs-ccB subtype |
2.028100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.049900E-02 |
| Normal-vs-N1 |
5.723000E-01 |
| N0-vs-N1 |
9.606400E-01 |
|
|
